Lakewood-Amedex partners with PERI for Nu-3 phase 2 trial
Tweet Send to a Friend
Lakewood-Amedex Biotherapeutics Inc. (NASDAQ: LABT) announced it has entered into an agreement with Professional Education and Research Institute LLC to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


